Featured Research

from universities, journals, and other organizations

Potential vaccine carrier may give stockpiling efforts a shot in the arm

Date:
April 22, 2012
Source:
Federation of American Societies for Experimental Biology (FASEB)
Summary:
A new potential vaccine carrier may extend the shelf life of and aid in the stockpiling of critical vaccines. A new microemulsion has been found to be both stable and a good candidate for delivering a variety of antigens.

Emulsions.
Credit: Courtesy of FASEB

A researcher at the Brooke Army Medical Center (BAMC)/San Antonio Military Medical Center (SAMMC) presented findings this week on a new potential vaccine carrier that he hopes will extend the shelf life of and aid in the stockpiling of critical vaccines.

Related Articles


U.S. Army Maj. Jean M. Muderhwa presented findings April 22, at the Experimental Biology 2012 meeting on a microemulsion he developed and that has been found to be both stable and a good candidate for delivering a variety of antigens. His findings were presented at the American Society for Biochemistry and Molecular Biology's annual meeting, which is part of EB2012.

"There is a synergy here," Muderhwa said of the microemulsion. "What I found is a composition that is transparent, is liquid and that has been sitting there (on my shelf) for six months" without degrading.

Muderhwa, deputy laboratory director at the Medical Center's Clinical Investigation Department, made the microemulsion with what seems like a simple recipe with five components, but it's how those five components interact that is quite special. He is hopeful that forthcoming animal studies will show the full potential for the recipe.

"There is a need (for new vaccine carriers like this) especially if we want to stockpile a vaccine," he emphasized. "The (U.S. Agency for International Development) and FDA are responsible for stocking, for example, the influenza vaccine in the case of epidemic. They have to deliver them as quickly as possible. So if you have a vaccine just sitting on the shelf for more than 10 or 20 years, you don't have to worry about its stability."

The first two parts of Muderhwa's concotion, oil and water, are the basis for just about any emulsion, many of which reside in most people's bathroom cabinets in the forms of creams and lotions. The third component, glycerol, is also used in a variety of skin-care products. The fourth component is a mixture of two high-molecular-weight, pharmaceutically acceptable surfactants (Span 80 and Tween 60). The fifth component, meanwhile, is an aluminum adjuvant-adsorbed protein used in vaccines to amplify the immune system's protective response to whatever antigen is being delivered.

Compared with the particles found in emulsions commonly used in creams and other substances applied topically, the particles in microemulsions are extremely tiny. And it's precisely this property that Muderhwa has harnessed and thinks deserves further study.

"If I were to make an emulsion (of oil and water), which is just a cream and white, that emulsion would separate within weeks," he said. "If you make a vaccine containing an emulsion, it's only (good for) probably a few months because the emulsion is not thermodynamically stable. The surface tension is too high, and the molecules are repelling one another until the emulsion fails."

An everyday example of this would be the separation of salad dressing left in a refrigerator or pantry for a couple of days. But when vaccines separate, giving them a good shake doesn't do the trick, making the administration of them more difficult.

"You can make those particles in a cream smaller and smaller and smaller," he explained. "The way you do that is you have to lower the surface tension to near zero. You know if you take water and put it in the oil, they don't mix. So you have to add a compound that can bring them together. If you take egg yolk -- it has phospholipids, and these are emulsifiers -- that helps to bring the water and oil to combine."

Muderhwa used a series of emulsifiers, such as Span 80 and Tween 60, and glycerol as the co-emulsifier needed to lower the surface tension of the tiny water and oil particles. That was only the first hurdle to overcome. The real worry was how the then-four-part compound would react if he added a fifth, the adjuvant needed to amplify the immune system's response to an antigen.

"Microemulsions are very sensitive to change. If you add an extra compound, they (also) separate quickly," he said. "But what I discovered is that, if I take … an aluminum adjuvant, which is the only one approved by the (Food and Drug Administration) to be used in humans, and I mix that microemulsion with the aluminum compound, … it is still stable."

The aluminum adjuvant Muderhwa used is found in the influenza vaccine.

While microemulsions are now used for drug delivery, such as antibiotics and syrups, using them for vaccines could open up a new area of study, Maj. Muderhwa said. These microemulsions are formed readily and sometimes spontaneously, he said.

"Another part of the presentation is for the future -- to tell people that these products can be used as a tool to investigate the effect of the surface area on the immune response," he explained. "If you make the molecules smaller and smaller and smaller, what happens? What happens if you increase the surface area? It will be interesting for research purposes to see the effects when the surface area increases on the immune response using this compound."

Born in the Democratic Republic of the Congo, Muderhwa earned his Ph.D. in biochemistry from the University of Languedoc Roussillon in Montpellier (France) and completed a postdoctoral stint in biophysics at the University of Minnesota. He's also worked at the Walter Reed Army Institute of Research, where he spent five years working on prostate cancer vaccines in Dr. Carl Alving's laboratory before joining the U.S. Army. Later on, he earned an MBA from Grantham University (St. Louis, Mo.) and a master's of public health from Kaplan University (Fort Lauderdale, Fla.).


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology (FASEB). Note: Materials may be edited for content and length.


Cite This Page:

Federation of American Societies for Experimental Biology (FASEB). "Potential vaccine carrier may give stockpiling efforts a shot in the arm." ScienceDaily. ScienceDaily, 22 April 2012. <www.sciencedaily.com/releases/2012/04/120422162219.htm>.
Federation of American Societies for Experimental Biology (FASEB). (2012, April 22). Potential vaccine carrier may give stockpiling efforts a shot in the arm. ScienceDaily. Retrieved November 21, 2014 from www.sciencedaily.com/releases/2012/04/120422162219.htm
Federation of American Societies for Experimental Biology (FASEB). "Potential vaccine carrier may give stockpiling efforts a shot in the arm." ScienceDaily. www.sciencedaily.com/releases/2012/04/120422162219.htm (accessed November 21, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Milestone Birthdays Can Bring Existential Crisis, Study Says

Milestone Birthdays Can Bring Existential Crisis, Study Says

Newsy (Nov. 21, 2014) Researchers find that as people approach new decades in their lives they make bigger life decisions. Video provided by Newsy
Powered by NewsLook.com
Ebola: Life Without School in Guinea

Ebola: Life Without School in Guinea

AFP (Nov. 21, 2014) Following the closure of schools and universities in Guinea because of the Ebola virus, students look for temporary work or gather in makeshift classrooms to catch up on their syllabus. Duration: 02:14 Video provided by AFP
Powered by NewsLook.com
UN Says It Will Scale Up Its Ebola Response

UN Says It Will Scale Up Its Ebola Response

AFP (Nov. 20, 2014) UN Resident Coordinator David McLachlan-Karr and WHO representative in the country Daniel Kertesz updated the media on the UN Ebola response on Wednesday. Duration: 00:51 Video provided by AFP
Powered by NewsLook.com
Takata Offers "sincerest Condolences" To Victims of Malfunctioning Airbag

Takata Offers "sincerest Condolences" To Victims of Malfunctioning Airbag

Reuters - US Online Video (Nov. 20, 2014) U.S. Congress hears from a victim and company officials as it holds a hearing on the safety of Takata airbags after reports of injuries. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins